4.3.1 Sintesi e raccomandazioni - Biblioteca Medica

(HoLRP) è meno costosa rispetto alla TURP [5].
Esistono infine altri lavori economici che considerano la rimozione precoce del catetere
[6] o l’implementazione di un modello assistenziale integrato [7] ed è stato identificato un
lavoro turco che non era una valutazione economica [8].
6.3.4.1. Bibliografia
1. Breda G, Xausa D, Gherardi L, Tamai A, Silvestre P, Giunta A. Rapporto costi-benefici tra
resezione endoscopica (TURP) e chirurgia a cielo aperto (Millin) nell’ipertrofia della
prostata. [Cost-benefit relationship between endoscopic resection (TURP) and open
surgery (Millin) in prostatic hypertrophy ]. Arch Ital Urol Nefrol Androl, 1990: 62,
329-332
2. Weis KA, Epstein RS, Huse DM, Deverka PA, Oster G. The costs of prostatectomy for
benign prostatic hyperplasia. Prostate, 1993: 22, 325-34.
3. Nathan MS, Wickham JEA. TVP: A cheaper and effective alternative to TURP. Minimally
Invasive Ther Allied Technol, 1996: 5, 292-296
4. Ahlstrand C, Carlsson P, Jonsson B. An estimate of the life-time cost of surgical treatment
of patients with benign prostatic hyperplasia in Sweden. Scand J Urol Nephrol, 1996:
30, 37-43.
5. Fraundorfer MR, Gilling PJ, Kennett KM, Dunton NG. Holmium laser resection of the
prostate is more cost effective than transurethral resection of the prostate: results of a
randomized prospective study. Urology, 2001: 57, 454-458
6. Mueller EJ, Zeidman EJ, Desmond PM, Thompson IM, Optenberg SA, Wasson J.
Reduction of length of stay and cost of transurethral resection of the prostate by early
catheter removal. Br J Urol, 1996: 78, 893-896.
7. Chang PL, Huang ST, Wang TM et al Improvements in the efficiency of care after
implementing a clinical care pathway for transurethal prostatectomy Br J Urol, 1998:
81, 394-97
8. Ilker Y, Tarcan T, Akdas A. Economics of different treatment options of benign prostatic
hyperplasia in Turkey. Int Urol Nephrol, 1996: 28, 525-528.
197